189 related articles for article (PubMed ID: 14746469)
1. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin.
Njardarson JT; Gaul C; Shan D; Huang XY; Danishefsky SJ
J Am Chem Soc; 2004 Feb; 126(4):1038-40. PubMed ID: 14746469
[TBL] [Abstract][Full Text] [Related]
2. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis.
Gaul C; Njardarson JT; Shan D; Dorn DC; Wu KD; Tong WP; Huang XY; Moore MA; Danishefsky SJ
J Am Chem Soc; 2004 Sep; 126(36):11326-37. PubMed ID: 15355116
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel migrastatin and dorrigocin A analogues from D-glucal.
Anquetin G; Rawe SL; McMahon K; Murphy EP; Murphy PV
Chemistry; 2008; 14(5):1592-600. PubMed ID: 18038383
[TBL] [Abstract][Full Text] [Related]
4. The total synthesis of (+)-migrastatin.
Gaul C; Njardarson JT; Danishefsky SJ
J Am Chem Soc; 2003 May; 125(20):6042-3. PubMed ID: 12785819
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Migrastatin Analogues as Inhibitors of Tumour Cell Migration: Exploring Structural Change in and on the Macrocyclic Ring.
Lo Re D; Zhou Y; Mucha J; Jones LF; Leahy L; Santocanale C; Krol M; Murphy PV
Chemistry; 2015 Dec; 21(50):17993. PubMed ID: 26537992
[TBL] [Abstract][Full Text] [Related]
6. Lactimidomycin, iso-migrastatin and related glutarimide-containing 12-membered macrolides are extremely potent inhibitors of cell migration.
Ju J; Rajski SR; Lim SK; Seo JW; Peters NR; Hoffmann FM; Shen B
J Am Chem Soc; 2009 Feb; 131(4):1370-1. PubMed ID: 19132897
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of (+)-isomigrastatin.
Krauss IJ; Mandal M; Danishefsky SJ
Angew Chem Int Ed Engl; 2007; 46(29):5576-9. PubMed ID: 17583888
[No Abstract] [Full Text] [Related]
8. Migrastatin acts as a muscarinic acetylcholine receptor antagonist.
Nakae K; Nishimura Y; Ohba S; Akamatsu Y
J Antibiot (Tokyo); 2006 Nov; 59(11):685-92. PubMed ID: 17256466
[TBL] [Abstract][Full Text] [Related]
9. Suppression of multidrug resistance by migrastatin.
Takemoto Y; Tashiro E; Imoto M
J Antibiot (Tokyo); 2006 Jul; 59(7):435-8. PubMed ID: 17025021
[TBL] [Abstract][Full Text] [Related]
10. Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities.
Nakae K; Yoshimoto Y; Sawa T; Homma Y; Hamada M; Takeuchi T; Imoto M
J Antibiot (Tokyo); 2000 Oct; 53(10):1130-6. PubMed ID: 11132958
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Migrastatin Analogues as Inhibitors of Tumour Cell Migration: Exploring Structural Change in and on the Macrocyclic Ring.
Lo Re D; Zhou Y; Mucha J; Jones LF; Leahy L; Santocanale C; Krol M; Murphy PV
Chemistry; 2015 Dec; 21(50):18109-21. PubMed ID: 26531227
[TBL] [Abstract][Full Text] [Related]
12. Iso-migrastatin congeners from Streptomyces platensis and generation of a glutarimide polyketide library featuring the dorrigocin, lactimidomycin, migrastatin, and NK30424 scaffolds.
Ju J; Lim SK; Jiang H; Seo JW; Shen B
J Am Chem Soc; 2005 Aug; 127(34):11930-1. PubMed ID: 16117518
[TBL] [Abstract][Full Text] [Related]
13. Thermolysis of isomigrastatin and its congeners via [3,3]-sigmatropic rearrangement: a new route to the synthesis of migrastatin and its analogues.
Ju J; Lim SK; Jiang H; Seo JW; Her Y; Shen B
Org Lett; 2006 Dec; 8(25):5865-8. PubMed ID: 17134292
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency.
Ju J; Rajski SR; Lim SK; Seo JW; Peters NR; Hoffmann FM; Shen B
Bioorg Med Chem Lett; 2008 Nov; 18(22):5951-4. PubMed ID: 18684620
[TBL] [Abstract][Full Text] [Related]
15. Concise total synthesis of the potent translation and cell migration inhibitor lactimidomycin.
Micoine K; Fürstner A
J Am Chem Soc; 2010 Oct; 132(40):14064-6. PubMed ID: 20831202
[TBL] [Abstract][Full Text] [Related]
16. Migrastatin analogues inhibit canine mammary cancer cell migration and invasion.
Majchrzak K; Lo Re D; Gajewska M; Bulkowska M; Homa A; Pawłowski K; Motyl T; Murphy PV; Król M
PLoS One; 2013; 8(10):e76789. PubMed ID: 24116159
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR
Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel taspine derivatives as antiangiogenic agents.
Zhang J; Zhang Y; Zhang S; Wang S; He L
Bioorg Med Chem Lett; 2010 Jan; 20(2):718-21. PubMed ID: 20006929
[TBL] [Abstract][Full Text] [Related]
19. Migrastatin and dorrigocins are shunt metabolites of iso-migrastatin.
Ju J; Lim SK; Jiang H; Shen B
J Am Chem Soc; 2005 Feb; 127(6):1622-3. PubMed ID: 15700980
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of eukaryotic translation elongation inhibitor lactimidomycin via Zn(II)-mediated Horner-Wadsworth-Emmons macrocyclization.
Larsen BJ; Sun Z; Nagorny P
Org Lett; 2013 Jun; 15(12):2998-3001. PubMed ID: 23731327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
